Navigation Links
KaloBios Provides Clinical Update and Reports Second Quarter Financial Results
Date:8/7/2014

ollaboration agreement with Sanofi Pasteur. KaloBios has stated that it intends to seek a partner with a focus on infectious disease, hospital pharmaceuticals, or cystic fibrosis who can accelerate and financially support the future development of KB001-A."We are very excited about the recent progress we have made on our programs," said Nestor A. Molfino, MD, MSc, Chief Medical Officer of KaloBios. "Completing enrollment in our Phase 2 KB001-A study in CF patients in a timeframe that will potentially allow us to report out top-line data in early 2015 was a major achievement for the company. At the same time, completing enrollment in the KB004 Phase 1 dose escalation study sets the stage for us to initiate enrollment in the high-dose cohorts in the Phase 2 efficacy-seeking portion of our KB004 study in the second half of 2014."

Key Anticipated Milestones for 2014-20152H 2014:Full enrollment of the KB001-A CF Phase 2 study (completed in July 2014)Q4 2014:

Completion of enrollment in at least one indication in the Phase 2 expansion portion of our KB004 study in hematologic malignanciesQ1 2015:

Top line KB001-A CF Phase 2 study resultsSecond Quarter 2014 Financial Results
Net loss for the three months ended June 30, 2014 was $9.8 million or $0.30 per common share, as compared to $11.8 million or $0.49 per common share for the same period in 2013. 

No contract revenue was reported for the second quarter of 2014 as compared to $15,000 reported in the same period in 2013. The decrease in contract revenues was due to the completion of all substantive performance obligations related to research support activities under our agreement with Sanofi Pasteur.

Research and development (R&D) expenses were $6.7 million for the three months ended June 30, 2014 as compared to $9.6 million for the same period in 2013. The decrease in R&D expense was primarily due to decreased clinical trial activity compared with the prior period
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. KaloBios Provides Update on KB001-A Partnership and Clinical Status
2. KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
3. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
4. KaloBios Elects Laurie Smaldone Alsup, M.D. to Board
5. KaloBios to Present at Leerink Swann Rare Disease Roundtable
6. KaloBios Pharmaceuticals, Inc. Prices Public Offering of Common Stock
7. Herb C. Cross to Join KaloBios as Chief Financial Officer
8. KaloBios KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
9. KaloBios to Present at Stifel Healthcare Conference 2013
10. KaloBios Reports First Quarter 2013 Financial Results
11. KaloBios to Present at Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 CVS Health Corporation (NYSE: CVS ... May 1, 2015, at 8:30 a.m. (EDT) with analysts ... An audio webcast of the conference call ... of the CVS Health website for all interested parties. ... webcast will be archived and available on the web ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ... Testing - Global Strategic Business Report" report to ... markets for ADME-Toxicology Testing in US$ Million by the ... Testing. The report provides separate comprehensive analytics ... Japan , Europe , ...
(Date:4/17/2015)... DIEGO , April 17, 2015  Trovagene, ... diagnostics, announced today that clinical data presented at ... that its urine-based Precision Cancer Monitoring ℠ ... and monitoring of EGFR T790M mutations ... Detection of EGFR T790M Mutation in Urinary ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... Intravenous Recombinant Factor IX (rFIX) Product for the Treatment ... Biopharmaceuticals, Inc., today announced the initiation of a Phase ... Factor IX (rFIX) product for control and prevention of ... is estimated that the market for therapies to treat ...
... the risk of cardiovascular hospitalization or death by 24 ... Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and ... that the ATHENA trial was published in the New ... (dronedarone), in addition to standard therapy, significantly reduced the ...
Cached Medicine Technology:Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 2New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 3New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 4New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 5New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation 6
(Date:4/18/2015)... (PRWEB) April 18, 2015 Carinsurancehints.com has released ... insurance plans that offer financial protection against fire damage. ... will pay benefits in case their vehicle is set intentionally ... vandalism caused by rioting or by other things. , ... quotes on a single website http://www.carinsurancehints.com/ , in ...
(Date:4/18/2015)... SMITHTOWN, NEW YORK (PRWEB) April 18, 2015 ... Inc. (AMO) are hosting a ‘Strategies for Success’ program ... & Refractive Surgeons meeting in San Diego, where eye ... ‘Distinguished Moderator’ for this invitation-only event. Dr. Martin is ... AMO and Review of Ophthalmology chose Dr. Martin to ...
(Date:4/18/2015)... Lower-auto-insurance.com has released a new blog post ... quotes . , Drivers can find accurate information ... professional insurance brokerage website can help drivers compare the ... convenient way. The whole process is designed to be ... online car insurance quotes is advantageous because it allows ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 In the ... a couple of changes. , "We had to run ... make needed changes," said Jennifer Ramirez, the PR Director. ... happy to say that we are back on track ... in the process of changing phone systems which has ...
(Date:4/18/2015)... 18, 2015 Aureus Medical Group ... including physical therapy jobs, has announced that it ... Carolina Physical Therapy Association Annual Conference to be ... in Greenville, SC. , The SCAPTA Annual ... with products and services. , Representatives from ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2
... HCA today announced the recipients of the ... a Physician Assistant at Wesley Medical Center in ... Northside Hospital in Macon, Ga., and Laurence Lesser, ... Center in Snellville. Ga., were honored today during ...
... Authority,s New GO! Gorgeous Kits Make Professional Skin Care Accessible ... lot on her plate. She,s picking up the kids, managing ... breadwinner. She works hard for the money, she deserves a ... take care of herself and present the best image possible."In ...
... Biology ConferenceOMAHA, Neb., April 20 ConAgra Foods announced ... Choice(R) really did get healthier. Participants in the 24-week ... fat - trimmed their waistlines by about three inches, ... Dr. James Rippe, founder and director of the Rippe ...
... to Go When Money Gets TightANN ARBOR, Mich., April 20 ... to a study released today by the Healthcare business of ... households postponed or cancelled care in the past year, a ... cancelled care, 24.1 percent of households cited cost as the ...
... careers, take online continuing education courses and network with other PT ... ... April 20, 2009 -- DavisPTnetwork - F. A. Davis Company,s ... physical therapists -- has already surpassed the 500-member mark. Launched ...
... a free website that lets cash-paying patients shop and ... 20 With an estimated 700,000 people ... without dental insurance, finding affordable healthcare ... who do have health insurance find that vision, dentistry, ...
Cached Medicine News:Health News:HCA Announces National 2008 Frist Humanitarian Award Recipients 2Health News:HCA Announces National 2008 Frist Humanitarian Award Recipients 3Health News:She Works Hard for the Money, so She Shouldn't Have to Work Hard for Great Skin 2Health News:She Works Hard for the Money, so She Shouldn't Have to Work Hard for Great Skin 3Health News:New Research Shows Healthy Choice Lives Up To Its Name 2Health News:New Research Shows Healthy Choice Lives Up To Its Name 3Health News:Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost 2Health News:Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost 3Health News:DavisPTnetwork, A Professional Social Network for Physical Therapists, Reaches Over 500 Members 2Health News:New Website Helps Families Find Better Healthcare at a Better Price 2
... Our Hand Held Nebulizer can be held at ... It has a built in spill column, finger ... for medication setups and 7 feet of regular ... plate maintain small particle size and sustain optimum ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
... ULTRA compressor. This high output compressor can ... medication to the patient's lungs. When combined ... LC STAR® Reusable Nebulizer, the particle size ... retention into the lungs. With less medication ...
... TREK™ Compact Compressor is for active patients ... anywhere and everywhere. The compressor is small ... source optionsworldwide AC compatibility (100 to 240V), ... patients the freedom to take aerosol treatments ...
Medicine Products: